Your browser doesn't support javascript.
Exacerbation of Erythema Nodosum Leprosum Possibly Triggered by COVID-19 Vaccine: A Case Report
Indian Journal of Leprosy ; 94(2):275-278, 2022.
Article in English | EMBASE | ID: covidwho-2083675
ABSTRACT
Erythema nodosum leprosum (ENL) is an immune complex mediated type III hypersensitivity reaction seen in patients of borderline lepromatous and lepromatous leprosy. It can be caused by a wide array of triggers and can be seen before, during, or after completion of anti-leprosy therapy. There are multiple well-known triggers for type 2 reactions like the initiation of multidrug therapy, Mantoux testing, vaccination, mental and physical stress, and physiological states like pregnancy. Herein, we report a case of exacerbation of ENL in a middle-aged woman, probably due to COVID-19 vaccine while she was well-controlled on immunosuppressive therapy. The episode was treated with non-steroid anti-inflammatory drugs and oral steroids and the symptoms resolved within 2 weeks. Although causality was highly possible between the occurrence of ENL and COVID-19 vaccine, physicians should be aware that it can be easily managed with proper care and medicines and this should not be a basis for deferring the vaccine. Copyright © Hind Kusht Nivaran Sangh, New Delhi.
Keywords
Search on Google
Collection: Databases of international organizations Database: EMBASE Type of study: Case report Topics: Vaccines Language: English Journal: Indian Journal of Leprosy Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: EMBASE Type of study: Case report Topics: Vaccines Language: English Journal: Indian Journal of Leprosy Year: 2022 Document Type: Article